表紙:抗凝固拮抗薬の世界市場:流通チャネル別・製品種類別・地域別の展望、業界分析、将来予測 (2021年~2027年)
市場調査レポート
商品コード
1009458

抗凝固拮抗薬の世界市場:流通チャネル別・製品種類別・地域別の展望、業界分析、将来予測 (2021年~2027年)

Global Anticoagulant Reversal Drugs Market By Distribution Channel, By Product Type, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

出版日: | 発行: KBV Research | ページ情報: 英文 169 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.81円
抗凝固拮抗薬の世界市場:流通チャネル別・製品種類別・地域別の展望、業界分析、将来予測 (2021年~2027年)
出版日: 2021年05月31日
発行: KBV Research
ページ情報: 英文 169 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗凝固拮抗薬の市場規模は、予測期間中に13.3%のCAGRで成長し続け、2027年までに16億米ドルに達すると予想されています。新型コロナウイルス感染症 (COVID-19) の重症患者向け治療の進展を受けて、抗凝固拮抗薬の需要の更なる拡大が見込まれています。流通チャネル別では小売薬局が、製品種類別ではイダルシズマブセグメントが最大のシェアを占めています。地域別に見ると、北米諸国が最大の市場であり、今後も市場成長をリードするものと思われます。

当レポートでは、世界の抗凝固拮抗薬の市場について分析し、製品の概要や市場の主な傾向、市場規模の動向見通し、流通チャネル別・製品種類別および地域別の詳細動向、主な市場促進・抑制要因、市場競争環境、主要企業のプロファイル、昨今の資本取引・事業戦略の展開状況、といった情報を取りまとめてお届けいたします。

目次

第1章 市場の範囲と分析手法

第2章 市場の概要

  • イントロダクション
  • 市場に影響を与える主な要因

第3章 世界の抗凝固拮抗薬市場:流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第4章 世界の抗凝固拮抗薬市場:製品種類別

  • イダルシズマブ
  • アンデキサネットα
  • プロトロンビン複合体濃縮物
  • フィトナジオン
  • プロタミン
  • その他

第5章 世界の抗凝固拮抗薬市場:地域別

  • 北米市場
  • 欧州市場
  • アジア太平洋市場
  • ラテンアメリカ・中東・アフリカ (LAMEA) 市場

第6章 企業プロファイル

  • Boehringer Ingelheim International GmbH
  • CSL Limited
  • Bausch Health Companies, Inc.
  • Octapharma AG
  • Pfizer, Inc.
  • Fresenius SE & Co. KGaA
  • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  • Dr. Reddy's Laboratories Ltd.
  • AMAG Pharmaceuticals, Inc. (Covis Pharma)
  • Alps Pharmaceutical Ind. Co., Ltd.
図表

LIST OF TABLES

  • TABLE 1 Global Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 2 Global Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 3 Global Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 4 Global Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 5 Global Hospital Pharmacy Market by Region, 2017 - 2020, USD Million
  • TABLE 6 Global Hospital Pharmacy Market by Region, 2021-2027, USD Million
  • TABLE 7 Global Retail Pharmacy Market by Region, 2017 - 2020, USD Million
  • TABLE 8 Global Retail Pharmacy Market by Region, 2021-2027, USD Million
  • TABLE 9 Global Online Pharmacy Market by Region, 2017 - 2020, USD Million
  • TABLE 10 Global Online Pharmacy Market by Region, 2021-2027, USD Million
  • TABLE 11 Global Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 12 Global Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 13 Global Idarucizumab Market by Region, 2017 - 2020, USD Million
  • TABLE 14 Global Idarucizumab Market by Region, 2021-2027, USD Million
  • TABLE 15 Global Andexanet Alfa Market by Region, 2017 - 2020, USD Million
  • TABLE 16 Global Andexanet Alfa Market by Region, 2021-2027, USD Million
  • TABLE 17 Global Prothrombin Complex Concentrates Market by Region, 2017 - 2020, USD Million
  • TABLE 18 Global Prothrombin Complex Concentrates Market by Region, 2021-2027, USD Million
  • TABLE 19 Global Phytonadione Market by Region, 2017 - 2020, USD Million
  • TABLE 20 Global Phytonadione Market by Region, 2021-2027, USD Million
  • TABLE 21 Global Protamine Market by Region, 2017 - 2020, USD Million
  • TABLE 22 Global Protamine Market by Region, 2021-2027, USD Million
  • TABLE 23 Global Other Product Type Market by Region, 2017 - 2020, USD Million
  • TABLE 24 Global Other Product Type Market by Region, 2021-2027, USD Million
  • TABLE 25 Global Anticoagulant Reversal Drugs Market by Region, 2017 - 2020, USD Million
  • TABLE 26 Global Anticoagulant Reversal Drugs Market by Region, 2021-2027, USD Million
  • TABLE 27 North America Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 28 North America Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 29 North America Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 30 North America Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 31 North America Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 32 North America Hospital Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 33 North America Retail Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 34 North America Retail Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 35 North America Online Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 36 North America Online Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 37 North America Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 38 North America Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 39 North America Idarucizumab Market by Country, 2017 - 2020, USD Million
  • TABLE 40 North America Idarucizumab Market by Country, 2021-2027, USD Million
  • TABLE 41 North America Andexanet Alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 42 North America Andexanet Alfa Market by Country, 2021-2027, USD Million
  • TABLE 43 North America Prothrombin Complex Concentrates Market by Country, 2017 - 2020, USD Million
  • TABLE 44 North America Prothrombin Complex Concentrates Market by Country, 2021-2027, USD Million
  • TABLE 45 North America Phytonadione Market by Country, 2017 - 2020, USD Million
  • TABLE 46 North America Phytonadione Market by Country, 2021-2027, USD Million
  • TABLE 47 North America Other Product Type Market by Country, 2017 - 2020, USD Million
  • TABLE 48 North America Other Product Type Market by Country, 2021-2027, USD Million
  • TABLE 49 North America Anticoagulant Reversal Drugs Market by Country, 2017 - 2020, USD Million
  • TABLE 50 North America Anticoagulant Reversal Drugs Market by Country, 2021-2027, USD Million
  • TABLE 51 US Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 52 US Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 53 US Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 54 US Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 55 US Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 56 US Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 57 Canada Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 58 Canada Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 59 Canada Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 60 Canada Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 61 Canada Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 62 Canada Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 63 Mexico Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 64 Mexico Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 65 Mexico Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 66 Mexico Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 67 Mexico Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 68 Mexico Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 69 Rest of North America Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 70 Rest of North America Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 71 Rest of North America Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 72 Rest of North America Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 73 Rest of North America Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 74 Rest of North America Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 75 Europe Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 76 Europe Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 77 Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 78 Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 79 Europe Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 80 Europe Hospital Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 81 Europe Retail Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 82 Europe Retail Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 83 Europe Online Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 84 Europe Online Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 85 Europe Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 86 Europe Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 87 Europe Idarucizumab Market by Country, 2017 - 2020, USD Million
  • TABLE 88 Europe Idarucizumab Market by Country, 2021-2027, USD Million
  • TABLE 89 Europe Andexanet Alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 90 Europe Andexanet Alfa Market by Country, 2021-2027, USD Million
  • TABLE 91 Europe Prothrombin Complex Concentrates Market by Country, 2017 - 2020, USD Million
  • TABLE 92 Europe Prothrombin Complex Concentrates Market by Country, 2021-2027, USD Million
  • TABLE 93 Europe Phytonadione Market by Country, 2017 - 2020, USD Million
  • TABLE 94 Europe Phytonadione Market by Country, 2021-2027, USD Million
  • TABLE 95 Europe Other Product Type Market by Country, 2017 - 2020, USD Million
  • TABLE 96 Europe Other Product Type Market by Country, 2021-2027, USD Million
  • TABLE 97 Europe Anticoagulant Reversal Drugs Market by Country, 2017 - 2020, USD Million
  • TABLE 98 Europe Anticoagulant Reversal Drugs Market by Country, 2021-2027, USD Million
  • TABLE 99 Germany Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 100 Germany Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 101 Germany Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 102 Germany Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 103 Germany Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 104 Germany Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 105 UK Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 106 UK Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 107 UK Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 108 UK Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 109 UK Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 110 UK Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 111 France Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 112 France Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 113 France Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 114 France Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 115 France Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 116 France Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 117 Russia Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 118 Russia Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 119 Russia Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 120 Russia Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 121 Russia Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 122 Russia Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 123 Spain Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 124 Spain Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 125 Spain Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 126 Spain Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 127 Spain Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 128 Spain Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 129 Italy Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 130 Italy Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 131 Italy Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 132 Italy Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 133 Italy Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 134 Italy Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 135 Rest of Europe Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 136 Rest of Europe Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 137 Rest of Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 138 Rest of Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 139 Rest of Europe Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 140 Rest of Europe Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 141 Asia Pacific Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 142 Asia Pacific Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 143 Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 144 Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 145 Asia Pacific Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 146 Asia Pacific Hospital Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 147 Asia Pacific Retail Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 148 Asia Pacific Retail Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 149 Asia Pacific Online Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 150 Asia Pacific Online Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 151 Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 152 Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 153 Asia Pacific Idarucizumab Market by Country, 2017 - 2020, USD Million
  • TABLE 154 Asia Pacific Idarucizumab Market by Country, 2021-2027, USD Million
  • TABLE 155 Asia Pacific Andexanet Alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 156 Asia Pacific Andexanet Alfa Market by Country, 2021-2027, USD Million
  • TABLE 157 Asia Pacific Prothrombin Complex Concentrates Market by Country, 2017 - 2020, USD Million
  • TABLE 158 Asia Pacific Prothrombin Complex Concentrates Market by Country, 2021-2027, USD Million
  • TABLE 159 Asia Pacific Phytonadione Market by Country, 2017 - 2020, USD Million
  • TABLE 160 Asia Pacific Phytonadione Market by Country, 2021-2027, USD Million
  • TABLE 161 Asia Pacific Other Product Type Market by Country, 2017 - 2020, USD Million
  • TABLE 162 Asia Pacific Other Product Type Market by Country, 2021-2027, USD Million
  • TABLE 163 Asia Pacific Anticoagulant Reversal Drugs Market by Country, 2017 - 2020, USD Million
  • TABLE 164 Asia Pacific Anticoagulant Reversal Drugs Market by Country, 2021-2027, USD Million
  • TABLE 165 China Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 166 China Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 167 China Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 168 China Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 169 China Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 170 China Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 171 Japan Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 172 Japan Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 173 Japan Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 174 Japan Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 175 Japan Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 176 Japan Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 177 India Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 178 India Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 179 India Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 180 India Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 181 India Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 182 India Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 183 South Korea Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 184 South Korea Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 185 South Korea Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 186 South Korea Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 187 South Korea Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 188 South Korea Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 189 Singapore Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 190 Singapore Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 191 Singapore Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 192 Singapore Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 193 Singapore Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 194 Singapore Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 195 Malaysia Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 196 Malaysia Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 197 Malaysia Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 198 Malaysia Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 199 Malaysia Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 200 Malaysia Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 201 Rest of Asia Pacific Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 202 Rest of Asia Pacific Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 203 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 204 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 205 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 206 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 207 LAMEA Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 208 LAMEA Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 209 LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 210 LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 211 LAMEA Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 212 LAMEA Hospital Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 213 LAMEA Retail Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 214 LAMEA Retail Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 215 LAMEA Online Pharmacy Market by Country, 2017 - 2020, USD Million
  • TABLE 216 LAMEA Online Pharmacy Market by Country, 2021-2027, USD Million
  • TABLE 217 LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 218 LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 219 LAMEA Idarucizumab Market by Country, 2017 - 2020, USD Million
  • TABLE 220 LAMEA Idarucizumab Market by Country, 2021-2027, USD Million
  • TABLE 221 LAMEA Andexanet Alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 222 LAMEA Andexanet Alfa Market by Country, 2021-2027, USD Million
  • TABLE 223 LAMEA Prothrombin Complex Concentrates Market by Country, 2017 - 2020, USD Million
  • TABLE 224 LAMEA Prothrombin Complex Concentrates Market by Country, 2021-2027, USD Million
  • TABLE 225 LAMEA Phytonadione Market by Country, 2017 - 2020, USD Million
  • TABLE 226 LAMEA Phytonadione Market by Country, 2021-2027, USD Million
  • TABLE 227 LAMEA Other Product Type Market by Country, 2017 - 2020, USD Million
  • TABLE 228 LAMEA Other Product Type Market by Country, 2021-2027, USD Million
  • TABLE 229 LAMEA Anticoagulant Reversal Drugs Market by Country, 2017 - 2020, USD Million
  • TABLE 230 LAMEA Anticoagulant Reversal Drugs Market by Country, 2021-2027, USD Million
  • TABLE 231 Brazil Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 232 Brazil Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 233 Brazil Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 234 Brazil Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 235 Brazil Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 236 Brazil Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 237 Argentina Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 238 Argentina Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 239 Argentina Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 240 Argentina Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 241 Argentina Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 242 Argentina Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 243 UAE Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 244 UAE Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 245 UAE Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 246 UAE Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 247 UAE Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 248 UAE Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 249 Saudi Arabia Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 250 Saudi Arabia Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 251 Saudi Arabia Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 252 Saudi Arabia Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 253 Saudi Arabia Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 254 Saudi Arabia Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 255 South Africa Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 256 South Africa Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 257 South Africa Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 258 South Africa Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 259 South Africa Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 260 South Africa Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 261 Nigeria Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 262 Nigeria Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 263 Nigeria Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 264 Nigeria Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 265 Nigeria Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 266 Nigeria Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 267 Rest of LAMEA Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
  • TABLE 268 Rest of LAMEA Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
  • TABLE 269 Rest of LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
  • TABLE 270 Rest of LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
  • TABLE 271 Rest of LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
  • TABLE 272 Rest of LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
  • TABLE 273 Key Information - Boehringer Ingelheim International GmbH
  • TABLE 274 key Information - CSL Limited
  • TABLE 275 key information - Bausch Health Companies, Inc.
  • TABLE 276 Key Information - Octapharma AG
  • TABLE 277 Key Information - Pfizer, Inc.
  • TABLE 278 key information - Fresenius SE & Co. KGaA
  • TABLE 279 key information - Alexion Pharmaceuticals, Inc.
  • TABLE 280 key information - Dr. Reddy's Laboratories Ltd.
  • TABLE 281 key information - AMAG Pharmaceuticals, Inc.
  • TABLE 282 key information - Alps Pharmaceutical Ind. Co., Ltd.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Recent strategies and developments: AMAG Pharmaceuticals, Inc.
目次

The Global Anticoagulant Reversal Drugs Market size is expected to reach $1.6 billion by 2027, rising at a market growth of 13.3% CAGR during the forecast period. Anticoagulant reversal is a medical procedure for the management of patients suffering from severe bleeding problems who are consuming an anticoagulant. Intake of reversal anticoagulant drug depends on type of anticoagulant a patient is taking. Though, majority of reversal agents can sometimes increase the risk of thromboembolic events. Therefore, these drugs should be used only in severe or life-threatening bleeding cases. Also, there should be thorough & careful monitoring of the Patients is required who are taking anticoagulation reversal drugs to avoid any untoward incident.

Hemophilia A and B, blood clots, and Von Willebrand disease (VWD) are some of the common bleeding disorders. As per the National Hemophilia Foundation (NHF), there are approximately 30,000 to 33,000 people in the U.S. who are suffering from hemophilia and about 60% of them have acute hemophilia. According to the CDC estimations, around 400 babies are born with hemophilia A per year. Von Willebrand disease is a very common bleeding disorder that affects 1 out of 100 individuals. Bleeding disorders affect blood clotting or may also cause undesirable bleeding from the patient's body. These blood-related disorders require anticoagulants that further boost the demand for anticoagulant reversal drugs in case of uncontrolled bleeding.

COVID-19 Impact

The sudden outbreak of COVID-19 has a significant impact on the anticoagulant reversal drugs with the growing number of research and development activities mainly on COVID-19 infection. For example, an article published in the American Journal of Cardiovascular Drugs in 2020 revealed that about 10 clinical trials are ongoing in order to evaluate how effective the factor Xa inhibitors are in COVID-19 patients. Research studies are continuing on developing the strategies for the parenteral administration of these drugs that are useful in the treatment of severe COVID-19 patients. Therefore, the COVID-19 pandemic would fuel the growth of the anticoagulant drug market.

Distribution Channel Outlook

Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. In 2020, the Retail pharmacy obtained the second-highest revenue share of the market. This segment includes specialty pharmacies and other retail pharmacies. Specialty drugs expected to grow at a considerable pace in the future pharmacy business. Moreover, the growth of the segment would be augmented by the factors like increasing penetration of retail pharmacies in developing economies having inadequate access to hospitals and online pharmacies.

Product Type Outlook

Based on Product Type, the market is segmented into Idarucizumab, Andexanet Alfa, Prothrombin Complex Concentrates, Phytonadione, Protamine and Others. The idarucizumab segment garnered the highest revenue share of the global market in 2020. It would showcase similar trend in the forecast period. This is due to the increasing revenue generation by idarucizumab in leading geographies across the globe.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as the leading region of the global market in 2020. It is likely to maintain this trend over the forecast period. The U.S. procured the highest share in the North American anticoagulant reversal drug market. The high healthcare expenditure and satisfactory healthcare reimbursement policies with respect to expensive drugs are the key driving factors in the market. In addition to it, the easy accessibility of these reversal drugs in an emergency situation also boosts the regional market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, CSL Limited, Bausch Health Companies, Inc., Octapharma AG, Pfizer, Inc., Fresenius SE & Co. KGaA, Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals), Dr. Reddy's Laboratories Ltd., AMAG Pharmaceuticals, Inc. (Covis Pharma), and Alps Pharmaceutical Ind. Co., Ltd.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Product Type

  • Idarucizumab
  • Andexanet Alfa
  • Prothrombin Complex Concentrates
  • Phytonadione
  • Protamine
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Boehringer Ingelheim International GmbH
  • CSL Limited
  • Bausch Health Companies, Inc.
  • Octapharma AG
  • Pfizer, Inc.
  • Fresenius SE & Co. KGaA
  • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  • Dr. Reddy's Laboratories Ltd.
  • AMAG Pharmaceuticals, Inc. (Covis Pharma)
  • Alps Pharmaceutical Ind. Co., Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Anticoagulant Reversal Drugs Market, by Distribution Channel
    • 1.4.2 Global Anticoagulant Reversal Drugs Market, by Product Type
    • 1.4.3 Global Anticoagulant Reversal Drugs Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition:
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints
    • 2.2.3 Opportunities:

Chapter 3. Global Anticoagulant Reversal Drugs Market by Distribution Channel

  • 3.1 Global Hospital Pharmacy Market by Region
  • 3.2 Global Retail Pharmacy Market by Region
  • 3.3 Global Online Pharmacy Market by Region

Chapter 4. Global Anticoagulant Reversal Drugs Market by Product Type

  • 4.1 Global Idarucizumab Market by Region
  • 4.2 Global Andexanet Alfa Market by Region
  • 4.3 Global Prothrombin Complex Concentrates Market by Region
  • 4.4 Global Phytonadione Market by Region
  • 4.5 Global Protamine Market by Region
  • 4.6 Global Other Product Type Market by Region

Chapter 5. Global Anticoagulant Reversal Drugs Market by Region

  • 5.1 North America Anticoagulant Reversal Drugs Market
    • 5.1.1 North America Anticoagulant Reversal Drugs Market by Distribution Channel
      • 5.1.1.1 North America Hospital Pharmacy Market by Country
      • 5.1.1.2 North America Retail Pharmacy Market by Country
      • 5.1.1.3 North America Online Pharmacy Market by Country
    • 5.1.2 North America Anticoagulant Reversal Drugs Market by Product Type
      • 5.1.2.1 North America Idarucizumab Market by Country
      • 5.1.2.2 North America Andexanet Alfa Market by Country
      • 5.1.2.3 North America Prothrombin Complex Concentrates Market by Country
      • 5.1.2.4 North America Phytonadione Market by Country
      • 5.1.2.5 North America Other Product Type Market by Country
    • 5.1.3 North America Anticoagulant Reversal Drugs Market by Country
      • 5.1.3.1 US Anticoagulant Reversal Drugs Market
        • 5.1.3.1.1 US Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.1.3.1.2 US Anticoagulant Reversal Drugs Market by Product Type
      • 5.1.3.2 Canada Anticoagulant Reversal Drugs Market
        • 5.1.3.2.1 Canada Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.1.3.2.2 Canada Anticoagulant Reversal Drugs Market by Product Type
      • 5.1.3.3 Mexico Anticoagulant Reversal Drugs Market
        • 5.1.3.3.1 Mexico Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.1.3.3.2 Mexico Anticoagulant Reversal Drugs Market by Product Type
      • 5.1.3.4 Rest of North America Anticoagulant Reversal Drugs Market
        • 5.1.3.4.1 Rest of North America Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.1.3.4.2 Rest of North America Anticoagulant Reversal Drugs Market by Product Type
  • 5.2 Europe Anticoagulant Reversal Drugs Market
    • 5.2.1 Europe Anticoagulant Reversal Drugs Market by Distribution Channel
      • 5.2.1.1 Europe Hospital Pharmacy Market by Country
      • 5.2.1.2 Europe Retail Pharmacy Market by Country
      • 5.2.1.3 Europe Online Pharmacy Market by Country
    • 5.2.2 Europe Anticoagulant Reversal Drugs Market by Product Type
      • 5.2.2.1 Europe Idarucizumab Market by Country
      • 5.2.2.2 Europe Andexanet Alfa Market by Country
      • 5.2.2.3 Europe Prothrombin Complex Concentrates Market by Country
      • 5.2.2.4 Europe Phytonadione Market by Country
      • 5.2.2.5 Europe Other Product Type Market by Country
    • 5.2.3 Europe Anticoagulant Reversal Drugs Market by Country
      • 5.2.3.1 Germany Anticoagulant Reversal Drugs Market
        • 5.2.3.1.1 Germany Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.2.3.1.2 Germany Anticoagulant Reversal Drugs Market by Product Type
      • 5.2.3.2 UK Anticoagulant Reversal Drugs Market
        • 5.2.3.2.1 UK Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.2.3.2.2 UK Anticoagulant Reversal Drugs Market by Product Type
      • 5.2.3.3 France Anticoagulant Reversal Drugs Market
        • 5.2.3.3.1 France Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.2.3.3.2 France Anticoagulant Reversal Drugs Market by Product Type
      • 5.2.3.4 Russia Anticoagulant Reversal Drugs Market
        • 5.2.3.4.1 Russia Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.2.3.4.2 Russia Anticoagulant Reversal Drugs Market by Product Type
      • 5.2.3.5 Spain Anticoagulant Reversal Drugs Market
        • 5.2.3.5.1 Spain Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.2.3.5.2 Spain Anticoagulant Reversal Drugs Market by Product Type
      • 5.2.3.6 Italy Anticoagulant Reversal Drugs Market
        • 5.2.3.6.1 Italy Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.2.3.6.2 Italy Anticoagulant Reversal Drugs Market by Product Type
      • 5.2.3.7 Rest of Europe Anticoagulant Reversal Drugs Market
        • 5.2.3.7.1 Rest of Europe Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.2.3.7.2 Rest of Europe Anticoagulant Reversal Drugs Market by Product Type
  • 5.3 Asia Pacific Anticoagulant Reversal Drugs Market
    • 5.3.1 Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel
      • 5.3.1.1 Asia Pacific Hospital Pharmacy Market by Country
      • 5.3.1.2 Asia Pacific Retail Pharmacy Market by Country
      • 5.3.1.3 Asia Pacific Online Pharmacy Market by Country
    • 5.3.2 Asia Pacific Anticoagulant Reversal Drugs Market by Product Type
      • 5.3.2.1 Asia Pacific Idarucizumab Market by Country
      • 5.3.2.2 Asia Pacific Andexanet Alfa Market by Country
      • 5.3.2.3 Asia Pacific Prothrombin Complex Concentrates Market by Country
      • 5.3.2.4 Asia Pacific Phytonadione Market by Country
      • 5.3.2.5 Asia Pacific Other Product Type Market by Country
    • 5.3.3 Asia Pacific Anticoagulant Reversal Drugs Market by Country
      • 5.3.3.1 China Anticoagulant Reversal Drugs Market
        • 5.3.3.1.1 China Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.3.3.1.2 China Anticoagulant Reversal Drugs Market by Product Type
      • 5.3.3.2 Japan Anticoagulant Reversal Drugs Market
        • 5.3.3.2.1 Japan Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.3.3.2.2 Japan Anticoagulant Reversal Drugs Market by Product Type
      • 5.3.3.3 India Anticoagulant Reversal Drugs Market
        • 5.3.3.3.1 India Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.3.3.3.2 India Anticoagulant Reversal Drugs Market by Product Type
      • 5.3.3.4 South Korea Anticoagulant Reversal Drugs Market
        • 5.3.3.4.1 South Korea Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.3.3.4.2 South Korea Anticoagulant Reversal Drugs Market by Product Type
      • 5.3.3.5 Singapore Anticoagulant Reversal Drugs Market
        • 5.3.3.5.1 Singapore Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.3.3.5.2 Singapore Anticoagulant Reversal Drugs Market by Product Type
      • 5.3.3.6 Malaysia Anticoagulant Reversal Drugs Market
        • 5.3.3.6.1 Malaysia Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.3.3.6.2 Malaysia Anticoagulant Reversal Drugs Market by Product Type
      • 5.3.3.7 Rest of Asia Pacific Anticoagulant Reversal Drugs Market
        • 5.3.3.7.1 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.3.3.7.2 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Product Type
  • 5.4 LAMEA Anticoagulant Reversal Drugs Market
    • 5.4.1 LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel
      • 5.4.1.1 LAMEA Hospital Pharmacy Market by Country
      • 5.4.1.2 LAMEA Retail Pharmacy Market by Country
      • 5.4.1.3 LAMEA Online Pharmacy Market by Country
    • 5.4.2 LAMEA Anticoagulant Reversal Drugs Market by Product Type
      • 5.4.2.1 LAMEA Idarucizumab Market by Country
      • 5.4.2.2 LAMEA Andexanet Alfa Market by Country
      • 5.4.2.3 LAMEA Prothrombin Complex Concentrates Market by Country
      • 5.4.2.4 LAMEA Phytonadione Market by Country
      • 5.4.2.5 LAMEA Other Product Type Market by Country
    • 5.4.3 LAMEA Anticoagulant Reversal Drugs Market by Country
      • 5.4.3.1 Brazil Anticoagulant Reversal Drugs Market
        • 5.4.3.1.1 Brazil Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.4.3.1.2 Brazil Anticoagulant Reversal Drugs Market by Product Type
      • 5.4.3.2 Argentina Anticoagulant Reversal Drugs Market
        • 5.4.3.2.1 Argentina Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.4.3.2.2 Argentina Anticoagulant Reversal Drugs Market by Product Type
      • 5.4.3.3 UAE Anticoagulant Reversal Drugs Market
        • 5.4.3.3.1 UAE Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.4.3.3.2 UAE Anticoagulant Reversal Drugs Market by Product Type
      • 5.4.3.4 Saudi Arabia Anticoagulant Reversal Drugs Market
        • 5.4.3.4.1 Saudi Arabia Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.4.3.4.2 Saudi Arabia Anticoagulant Reversal Drugs Market by Product Type
      • 5.4.3.5 South Africa Anticoagulant Reversal Drugs Market
        • 5.4.3.5.1 South Africa Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.4.3.5.2 South Africa Anticoagulant Reversal Drugs Market by Product Type
      • 5.4.3.6 Nigeria Anticoagulant Reversal Drugs Market
        • 5.4.3.6.1 Nigeria Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.4.3.6.2 Nigeria Anticoagulant Reversal Drugs Market by Product Type
      • 5.4.3.7 Rest of LAMEA Anticoagulant Reversal Drugs Market
        • 5.4.3.7.1 Rest of LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel
        • 5.4.3.7.2 Rest of LAMEA Anticoagulant Reversal Drugs Market by Product Type

Chapter 6. Company Profiles

  • 6.1 Boehringer Ingelheim International GmbH
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Regional & Segmental Analysis
    • 6.1.4 Research & Development Expenses
  • 6.2 CSL Limited
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Segmental and Regional Analysis
    • 6.2.4 Research & Development Expense
  • 6.3 Bausch Health Companies, Inc.
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental and Regional Analysis
    • 6.3.4 Research & Development Expense
  • 6.4 Octapharma AG
    • 6.4.1 Company Overview
  • 6.5 Pfizer, Inc.
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Regional Analysis
    • 6.5.4 Research & Development Expense
  • 6.6 Fresenius SE & Co. KGaA
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental and Regional Analysis
    • 6.6.4 Research & Development Expenses
  • 6.7 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Regional Analysis
    • 6.7.4 Research & Development Expense
    • 6.7.5 Recent strategies and developments:
      • 6.7.5.1 Approvals:
  • 6.8 Dr. Reddy's Laboratories Ltd.
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Segmental and Regional Analysis
    • 6.8.4 Research & Development Expense
  • 6.9 AMAG Pharmaceuticals, Inc. (Covis Pharma)
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Research & Development Expenses
    • 6.9.4 Recent strategies and developments:
      • 6.9.4.1 Partnerships, Collaborations, and Agreements:
      • 6.9.4.2 Acquisition and Mergers:
  • 6.10. Alps Pharmaceutical Ind. Co., Ltd.
    • 6.10.1 Company Overview